Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-039699
Filing Date
2013-05-09
Accepted
2013-05-09 17:26:24
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a13-8599_110q.htm 10-Q 911426
2 EX-31.1 a13-8599_1ex31d1.htm EX-31.1 9694
3 EX-31.2 a13-8599_1ex31d2.htm EX-31.2 9718
4 EX-32.1 a13-8599_1ex32d1.htm EX-32.1 8142
  Complete submission text file 0001104659-13-039699.txt   6652177

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT fold-20130331.xml EX-101.INS 760158
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20130331.xsd EX-101.SCH 74417
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20130331_cal.xml EX-101.CAL 59700
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20130331_def.xml EX-101.DEF 277661
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT fold-20130331_lab.xml EX-101.LAB 1130085
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20130331_pre.xml EX-101.PRE 535365
Mailing Address 6 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 6 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 13830185
SIC: 2834 Pharmaceutical Preparations